Apotex Inc., one of Canada’s largest pharmaceutical companies, has just made a bold move to be at the forefront of this transformation. The company announced the acquisition of CanPrev marking the company’s official entry into the booming health and wellness industry.
This strategic acquisition signals a major step forward for Apotex as it expands beyond traditional pharmaceuticals and into the world of vitamins, supplements, and natural health products—a sector experiencing growing consumer demand. CanPrev, known for its CanPrev, Cyto-Matrix, and Orange Naturals brands, brings a diverse portfolio of over 445 products, available in more than 3,400 retail locations across Canada, from pharmacies and health food stores to grocery chains and online platforms.
A Natural Fit for Apotex’s Growth Strategy
For Apotex, this acquisition isn’t just about expansion—it’s about meeting the changing needs of consumers. Canadians are increasingly looking for natural, preventative health solutions, and with CanPrev’s strong reputation among both consumers and health professionals, Apotex is well-positioned to deliver.
“The acquisition of CanPrev advances Apotex further along on our Journey of Health growth strategy,” said Allan Oberman, President & CEO of Apotex. “It strategically complements our ongoing focus to expand high-value products to consumers and provides us with the opportunity for expansion into select international markets.”
With its established pharmacy presence, Apotex will now be able to broaden its reach into health food stores, naturopathic clinics, and new retail channels, opening doors for even greater accessibility to CanPrev’s trusted products.
A Shared Commitment to Quality & Innovation
For Franco and Tanya Salituro, founders of CanPrev, this acquisition represents an exciting new chapter in their company’s journey.
“We are excited for CanPrev to embark on this new chapter with Apotex, a Canadian-based global health leader,” they shared. “Under Apotex’s ownership, we have an ally and a champion for the natural health industry, opening incredible opportunities for CanPrev to expand its reach and deliver high-quality products to broader audiences.”
Apotex’s established legacy in research, innovation, and pharmaceutical excellence aligns seamlessly with CanPrev’s commitment to science-backed natural health solutions. This union promises exciting developments in product innovation, as well as greater availability of trusted, high-quality supplements for Canadians.
What’s Next?
While CanPrev will continue to operate under its existing brand and distribution channels, consumers can expect increased accessibility to its products across Canada. Additionally, the acquisition sets the stage for future global expansion, bringing CanPrev’s renowned products to new markets through Apotex’s international network.
With the Canadian health and wellness sector on a steady upward trajectory, this acquisition is not just a business move—it’s a reflection of the changing healthcare landscape. As more Canadians prioritize preventative health and natural solutions, Apotex’s entry into this space ensures that trusted, high-quality supplements are more accessible than ever.
